Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 3
1985 1
1987 1
1988 1
1989 1
1990 4
1991 1
1992 2
1993 4
1994 2
1997 2
1998 5
1999 2
2000 2
2001 2
2003 7
2004 8
2005 9
2006 8
2007 8
2008 7
2009 8
2010 13
2011 13
2012 14
2013 22
2014 22
2015 16
2016 20
2017 25
2018 19
2019 32
2020 24
2021 22
2022 23
2023 18
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Refractory hypothyroidism.
Lai YY, Thambiah SC, Mohamed Mokhtar N, Samsudin IN. Lai YY, et al. Malays J Pathol. 2024 Apr;46(1):109-113. Malays J Pathol. 2024. PMID: 38682851 Free article.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Striatal mechanism of the restless legs syndrome.
Lai YY, Hsieh KC, Chew KT, Nguyen D, Siegel JM. Lai YY, et al. Sleep. 2022 Jul 11;45(7):zsac110. doi: 10.1093/sleep/zsac110. Sleep. 2022. PMID: 35537196 Free PMC article.
Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.
Courtney MJ, Li LL, Lai YY. Courtney MJ, et al. Among authors: lai yy. Front Cell Neurosci. 2014 Aug 27;8:252. doi: 10.3389/fncel.2014.00252. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25221472 Free PMC article. Review.
355 results